Evidence map›Paper›PMID 34258278›Full record

ArticleBioMed research international2021

Genome Features and

Irina V Soloveva, Tatyana N Ilyicheva, Vasiliy Yu Marchenko, Oleg V Pyankov, Anna G Tochilina, Irina V Belova, Vladimir A Zhirnov, Nikolay I Bormotov, Maksim O Skarnovich, Aleksander G Durymanov and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Functional foods with antiviral activity.Food science and biotechnology · 2022
    Review
  4. The Beneficial Role of ProbioticFrontiers in immunology · 2022
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Irina V SolovevaAcademician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, 71, M. Yamskaya Street, Nizhny Novgorod 603950, Russia.ORCID https://orcid.org/0000-0002-3136-9500
Tatyana N IlyichevaVector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia.ORCID https://orcid.org/0000-0002-2354-7688
Vasiliy Yu MarchenkoVector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia.ORCID https://orcid.org/0000-0002-1339-6732
Oleg V PyankovVector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia.ORCID https://orcid.org/0000-0003-3340-8750
Anna G TochilinaAcademician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, 71, M. Yamskaya Street, Nizhny Novgorod 603950, Russia.ORCID https://orcid.org/0000-0001-7753-5730
Irina V BelovaAcademician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, 71, M. Yamskaya Street, Nizhny Novgorod 603950, Russia.ORCID https://orcid.org/0000-0003-3402-1160
Vladimir A ZhirnovAcademician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, 71, M. Yamskaya Street, Nizhny Novgorod 603950, Russia.ORCID https://orcid.org/0000-0002-1162-2417
Nikolay I BormotovVector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia.
Maksim O SkarnovichVector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia.
Aleksander G DurymanovVector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia.ORCID https://orcid.org/0000-0001-5634-1785
Svetlana B MolodtsovaAcademician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, 71, M. Yamskaya Street, Nizhny Novgorod 603950, Russia.ORCID https://orcid.org/0000-0002-4750-5925
Ekaterina I FilippovaVector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia.
Alena S OvchinnikovaVector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia.
Anastasia V MagerramovaVector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia.
Alexander B RyzhikovVector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia.ORCID https://orcid.org/0000-0002-7009-0748
Rinat A MaksyutovVector State Research Centre of Virology and Biotechnology, Koltsovo, Novosibirsk Region 630559, Russia.ORCID https://orcid.org/0000-0003-1314-281X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this work was to analyze the complete genome of probiotic bacteria

methodsTo confirm the taxonomic affiliation of the bacterial strains, MALDI TOF mass spectrometry and biochemical test systems were used. Whole genome sequencing was performed on the Illumina Inc. MiSeq platform. To determine the antiviral activity, A/Lipetsk/1V/2018 (H1N1 pdm09) (EPI_ISL_332798) and A/common gull/Saratov/1676/2018 (H5N6) (EPI_ISL_336925) influenza viruses and SARS-CoV-2 virus strain Australia/VIC01/2020 (GenBank: MT007544.1) were used.

resultsAll studied probiotic bacteria are nonpathogenic for humans and do not contain the determinants of transmission-type antibiotic resistance and integrated plasmids. Resistance to antibiotics of different classes is explained by the presence of molecular efflux pumps of the MatE and MFS families. Cultures of

conclusionsThe studied probiotic bacteria are safe, have antiviral activity, and are of great importance for the prevention of diseases caused by respiratory viruses that can also infect the human intestine.

Indexed as

AnimalsBifidobacterium longumChlorocebus aethiopsCOVID-19DogsHigh-Throughput Nucleotide SequencingHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanLactobacillusMadin Darby Canine Kidney CellsProbioticsSARS-CoV-2Vero Cells

Identifiers

PMID34258278
PMCPMC8225420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.